Home

Godavari Drugs Ltd EPS

Image

Godavari Drugs Ltd

NSE: GODAVARIDRUGS

EPS

₹ 8.21

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Godavari Drugs Ltd is ₹ 8.21 as of 21 Feb 25 .
  • The earning per share of Godavari Drugs Ltd changed from ₹ 1.08 to ₹ 1.02 over 7 quarters. This represents a CAGR of -3.21% .

Historical Earning per Share of Godavari Drugs Ltd

No data available

* All values are in

Company Fundamentals for Godavari Drugs Ltd

Market Cap

65 Cr

EPS

8.2

P/E Ratio (TTM)

10.6

P/B Ratio (TTM)

1.6

Day’s High

93.0

Day’s Low

86.25

DTE

1.4

ROE

15.8

52 Week High

155.0

52 Week Low

81.15

ROCE

12.8

Market Price of Godavari Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Godavari Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202587.45
20 Feb 202585.45
19 Feb 202587.25
18 Feb 202584.05
17 Feb 202587.35
14 Feb 202590
13 Feb 202593.7
12 Feb 202597.4
11 Feb 2025101.35
10 Feb 2025103.4

SWOT Analysis Of Godavari Drugs Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Godavari Drugs Ltd

Asset Value vs Market Value of Godavari Drugs Ltd

Market Value

66

-0.3 X

Value addition

Asset Value

88

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Godavari Drugs Ltd65.85
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Godavari Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Godavari Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Godavari Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Godavari Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Godavari Drugs Ltd News Hub

Godavari Drugs standalone net profit rises 101.23% in the June 2024 quarter

Net profit of Godavari Drugs rose 101.23% to Rs 1.63 crore in the quarter ended June 2024 as against

Read more

14 Aug 24

Godavari Drugs to discuss results

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2024. Power

Read more

10 Aug 24

Godavari Drugs standalone net profit rises 26.74% in the September 2024 quarter

Net profit of Godavari Drugs rose 26.74% to Rs 1.09 crore in the quarter ended September 2024 as aga

Read more

14 Nov 24

Godavari Drugs to convene board meeting

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024 Powe

Read more

09 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Godavari Drugs Ltd

What is the EPS of Godavari Drugs Ltd stock?

The Earnings Per Share (EPS) of Godavari Drugs Ltd is 8.21. An EPS is the amount of net income attributed to each share of a common stock.

How is Godavari Drugs Ltd EPS calculated?

The EPS of Godavari Drugs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Godavari Drugs Ltd report its EPS?

Godavari Drugs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Godavari Drugs Ltd EPS?

Factors that influence the EPS of Godavari Drugs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Godavari Drugs Ltd EPS growth indicate future performance?

Yes, consistent growth in Godavari Drugs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions